Position in NVS
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$1,459,063
+$236,758 QoQ
Shares Held
9,310
+16.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#513
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $209,939,553 across 14 Drug Manufacturers - General names. NVS ranks #9 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
130,247 | $156,222,172 | |
| 2 | JNJ |
Johnson & Johnson
|
62,574 | $15,891,918 | |
| 3 | ABBV |
AbbVie Inc.
|
47,980 | $12,073,687 | |
| 4 | MRK |
Merck & Co., Inc.
|
54,116 | $6,953,906 | |
| 5 | AMGN |
Amgen Inc
|
17,375 | $6,291,835 | |
| 6 | PFE |
Pfizer Inc
|
169,378 | $4,078,622 | |
| 7 | AZN |
Astrazeneca PLC
|
9,817 | $1,861,499 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,784 | $1,716,154 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,459,063 | 9,310 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $1,222,305 | 8,002 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,495,613 | 10,848 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,275,859 | 9,949 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,121,278 | 9,266 | Shares | Sole | 2025-09-12 | |
| 2025-03-31 | $949,809 | 8,520 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $658,302 | 6,765 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $770,749 | 6,701 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $713,388 | 6,701 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $679,238 | 7,022 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $673,671 | 6,672 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $696,518 | 6,838 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $743,000 | 7,363 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $622,012 | 6,761 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $463,942 | 5,114 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $266,871 | 3,511 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $248,180 | 2,936 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $282,818 | 3,223 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $689,438 | 7,882 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $631,014 | 7,716 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $647,804 | 7,100 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $644,006 | 7,534 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $680,840 | 7,210 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $626,112 | 7,200 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $710,685 | 8,137 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $199,034 | 2,414 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||